Answers are grounded in this paper and cite their sources.
The results of this study show that IGIV-C was effective, safe, and well tolerated in the treatment of MG exacerbations.
No takes yet. Share an insight, caveat, or question.
Karelis et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: